Ceftolozane Tazobactam – Injection products
Exceptions or additions to the recognized standards
Minimum Inhibitory | Disk Diffusion | |||||
---|---|---|---|---|---|---|
Pathogen | S | I | R | S | I | R |
Bacteroides fragilis | ≤8/4 | 16/4 | ≥32/4 | - | - | - |
S = Susceptible; I = Intermediate; R = Resistant
STIC are based on a dose for adults of 1.5g every 8 h for the treatment of complicated intra-abdominal infections and complicated urinary tract infections or a dose of 3 g every 8 h for the treatment of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia.